Adipose Tissue Derived Stromal Vascular Fraction (SVF) Application in Treatment of Long Bones Nonunion

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

November 10, 2019

Primary Completion Date

February 14, 2020

Study Completion Date

February 14, 2020

Conditions
Nonunion of Fracture
Interventions
BIOLOGICAL

autologous adipose tissue derived stromal vascular fraction (SVF)

"liquid and solid portion of lipo-aspirate after non enzymatic processing yields SVF.~This isolation process yielded an abundant population of Adipose stromal cells(ASCs) which have multipotent differentiation potential. Immunophenotype is a CD14-, CD29+, CD31-, CD34low/+, CD45-, CD73+ and CD105+ ,~, the SVF represents the 50-70% in volume of a lipoaspirate specimen. The SVF hosts a heterogeneous cell population (110x103 cells/ml on average) comprising mainly CD105+ mesenchymal stem cells (MSC, 20%), plus a wide number of CD34+ hematopoietic cells (40%)."

Trial Locations (1)

263153

Anupam Hospital, Rudrapur

All Listed Sponsors
lead

Dr. Himanshu Bansal Foundation

OTHER

NCT04340284 - Adipose Tissue Derived Stromal Vascular Fraction (SVF) Application in Treatment of Long Bones Nonunion | Biotech Hunter | Biotech Hunter